These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25063949)

  • 1. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
    Basu A; Jenkins AJ; Stoner JA; Thorpe SR; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2014 Sep; 236(1):188-195. PubMed ID: 25063949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study.
    Dietrich M; Jacques PF; Polak JF; Keyes MJ; Pencina MJ; Evans JC; Wolf PA; Selhub J; Vasan RS; D'Agostino RB
    J Stroke Cerebrovasc Dis; 2011; 20(2):155-61. PubMed ID: 20580253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.
    Uysal O; Arikan E; Cakir B
    J Endocrinol Invest; 2005 Nov; 28(10):928-34. PubMed ID: 16419496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of homocysteine on carotid intima-media thickness after renal transplantation.
    Suwelack B; Gerhardt U; Witta J; Rahn KH; Hohage H
    Clin Transplant; 2000 Dec; 14(6):555-60. PubMed ID: 11127308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF; Backlund JC; Budoff M; Raskin P; Bebu I; Lachin JM;
    J Am Heart Assoc; 2021 Dec; 10(24):e022922. PubMed ID: 34873921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
    Nathan DM; Lachin J; Cleary P; Orchard T; Brillon DJ; Backlund JY; O'Leary DH; Genuth S; ;
    N Engl J Med; 2003 Jun; 348(23):2294-303. PubMed ID: 12788993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
    Held C; Sumner G; Sheridan P; McQueen M; Smith S; Dagenais G; Yusuf S; Lonn E
    Vasc Med; 2008 Nov; 13(4):245-53. PubMed ID: 18940900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
    Basu A; Jenkins AJ; Stoner JA; Zhang Y; Klein RL; Lopes-Virella MF; Garvey WT; Schade DS; Wood J; Alaupovic P; Lyons TJ;
    J Lipid Res; 2018 May; 59(5):872-883. PubMed ID: 29576550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cardiovascular risk factors on the carotid intima-media thickness in an old-aged cohort with hypertension: a longitudinal evolution with 4-year follow-up of a random clinical trial.
    Zhao XX; Liu J; Zhao H; Zhou Y; Li L; Wang H
    Clin Exp Hypertens; 2019; 41(1):49-57. PubMed ID: 29553852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.
    Jaffa MA; Luttrell D; Schmaier AH; Klein RL; Lopes-Virella M; Luttrell LM; Jaffa AA;
    Diabetes; 2016 Feb; 65(2):498-502. PubMed ID: 26603531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.
    Aso Y; Okumura K; Takebayashi K; Wakabayashi S; Inukai T
    Diabetes Care; 2003 Sep; 26(9):2622-7. PubMed ID: 12941729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Timothy Garvey W; Lyons TJ;
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
    Hunt KJ; Baker N; Cleary P; Backlund JY; Lyons T; Jenkins A; Virella G; Lopes-Virella MF;
    Atherosclerosis; 2013 Dec; 231(2):315-22. PubMed ID: 24267245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.